Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus

NCT00376181 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

96

Enrollment

INDUSTRY

Sponsor class

Stopped Combination formulation concerns

Conditions

Type 2 Diabetes

Interventions

DRUG: Pioglitazone and Azilsartan
DRUG: Pioglitazone and Azilsartan
DRUG: Pioglitazone

Sponsor

Takeda